SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as traders debate its potential for a parabolic rally, with many in the community closely monitoring technical indicators and chart patterns for a breakout. Investors are actively discussing the coin's future as a major crypto asset, balancing high hopes for institutional adoption against frustration over its recent price stagnation.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative interest as traders discuss its potential role in Japan's expanding IoT and tokenized data ecosystem. The community remains deeply divided, with long-term holders pointing to long-term accumulation and partnership rumors, while skeptics emphasize the lack of recent price momentum and competitive shifts within the project's leadership.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy is active and buzzing with speculative momentum as traders rotate between $MULN and associated tokens, fueled by community-led 'pump' narratives. Despite persistent warnings from some users about the project's controversial history, participants are rallying around high-risk, low-market-cap trading strategies in hopes of repeating past volatility.

Ascend is a prediction perpetuals platform that allows you to trade prediction markets with up to 100x leverage. Ascend is multi-chain, ZK-settled on Midnight, secured by Cardano. Ascend turns prediction markets into real-time, tradable markets. Instead of simply betting on outcomes and waiting for resolution, users can trade the probability of events (like BTC hitting $100K) using a perpetual-style engine, entering and exiting positions anytime. Trades are executed off-chain for speed and then batch-settled on Midnight using zero-knowledge (ZK) proofs, giving users a seamless experience with strong on-chain guarantees. This creates a more dynamic, liquid, and capital-efficient way to trade information and belief.

Project Ascend

Project Ascend is capturing significant investor attention as the community anticipates a major rally following the upcoming main-net launch and current consolidation phase. Market participants are actively buzzing about the project's growth potential, framing the current price action as a key accumulation opportunity.

ARK ETF Trust - ARK Space & Defense Innovation ETF

ARK Space Exploration & Innovation ETF

The ARK Space Exploration & Innovation ETF is garnering significant attention as investors speculate on its potential to capitalize on the growing space economy, particularly with ongoing excitement surrounding a possible SpaceX IPO. Community members are actively debating the fund's current holdings and comparing it to other space-focused investment vehicles while watching for future portfolio shifts.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is currently drawing significant community attention as investors debate its long-term utility versus recent price underperformance, with many actively discussing the impact of upcoming network upgrades like Hayabusa and the EU's Digital Product Passport. While some holders remain hopeful that these institutional adoption catalysts will fuel a recovery, others express frustration over stagnant growth and the foundation's treasury management, fueling intense debates on social platforms about whether the asset is finally poised for a turnaround or entering a cycle of decline.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is gaining significant community attention as investors highlight its deflationary burn mechanisms and expanding decentralized AI ecosystem, with many participants actively discussing potential price momentum fueled by privacy-focused AI narratives. The conversation is currently dominated by 'true long' bulls who view the token as a long-term play on artificial intelligence, frequently comparing its current market cap to other sector leaders while anticipating further ecosystem developments.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad ($GIGA) is trending as the community rallies around its unique expansion into physical retail supplements and its persistent presence in internet culture. Supporters are actively highlighting its role as a long-term 'asymmetric' play, often drawing comparisons to other major meme assets while emphasizing the importance of community conviction through market volatility.

MarketWise, Inc. develops and operates a multi-brand digital subscription services platform. It is a subscription services platform that provides independent financial research, analytical tools, and software primarily to retail investors across digital channels. The company was founded in 1999 and is headquartered in Baltimore, MD.

Marketwise Inc - Ordinary Shares - Class A

MarketWise is attracting community interest as investors weigh its recent billing growth and profitability against a complex capital structure and historical share price volatility. Discussions are centered on the stock's status as a deep-value play, with many participants monitoring insider accumulation and potential acquisition interest in the digital subscription platform.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently drawing significant attention from investors as it aggressively scales its 'physical AI' infrastructure and secures major partnerships, most notably with Volkswagen, to integrate its autonomous driving software. The community remains deeply divided, with bulls pointing to these high-tech milestones and global expansion plans as evidence of long-term value, while bears focus on delivery volatility and ongoing downward price pressure from institutional trading patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028

ENvue Medical renewed a three-year purchasing agreement covering 90-plus hospitals across 17 states through 2028.read more...

What's Going On With ENvue Medical Stock On Thursday?

ENvue Medical shares slip premarket on Thursday after rally as Detroit hospital purchase lifts adoption to 39 sites.read more...

What's Behind The Jump In ENvue Medical Stock Today?

Shares of ENvue Medical, Inc. (NASDAQ: FEED) are surging on Tuesday after the company disclosed a new hospital system win that lifts its U.S. footprint to 39 hospitals.read more...

Small Caps Push Big Narratives, as Innovation Drives

It’s a relatively quiet session across broader markets, but beneath the surface, a wave of company-specific developments will keep traders engaged. $KBLB, $RAYA, $FEED, $ELAB, $YMT, $PAVS, $UGRO

Insider Buying: Nanovibronix (NASDAQ:FEED) Major Shareholder Purchases 240,000 Shares of Stock

Nanovibronix, Inc. (NASDAQ:FEED - Get Free Report) major shareholder Christian Michael Glibert purchased 240,000 shares of the firm's stock in a transaction dated Wednesday, January 14th. The stock...

<ul class="summary-bullets"><li>The agreement is aimed at distributing Texas-based ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide.&nbsp;</li><li>The syringes were launched earlier this month and are designed to meet both feeding and medication delivery clinical needs.&nbsp;</li><li>The new deal would utilize U-Deliver’s digital and wholesale channels to broaden access to the syringes launched earlier this month.&nbsp; &nbsp;</li></ul>Shares of ENvue Medical, Inc. (FEED) jumped 138% on Wednesday after the company announced a distribution agreement with enteral feeding supplies provider U-Deliver.The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/28/3227664/0/en/ENvue-Medical-Signs-Strategic-Partnership-Agreement-with-U-Deliver-for-U-S-Distribution-of-Over-the-Counter-Reusable-ENFit-Syringe-Line.html">agreement</a> is aimed at distributing Texas-based ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels. The deal would utilize U-Deliver’s digital and wholesale channels to broaden access to the syringes launched earlier this month.<h2 class="st-heading-2">About ENVue Syringes</h2>ENvue’s ENFit Syringes are currently available through U-Deliver’s website, Amazon storefront, and wholesale channels in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes. These syringes, designed for reuse for up to seven days or 20 uses, do not require a prescription. They are also designed to meet both feeding and medication delivery clinical needs.ENVue was formerly called NanoVibronix. The company switched names to reflect its focus on the ENvue feeding-tube placement system, which it gained access to with the acquisition of privately-held ENvue Medical Holdings Corp in February 2025.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around FEED rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘extremely high’ levels.A Stocktwits user said that they sold their shares in the company for a 20% profit.<stembedurl>https://www.stocktwits.com/NathanN23/message/643168472</stembedurl>Another user, however, highlighted the company’s “insanely low” market cap, adding that it is less than someone's net worth.<stembedurl>https://www.stocktwits.com/Shorting_BTC_Since_2009/message/643160653</stembedurl>Yet another user predicted upcoming dilution efforts.<stembedurl>https://www.stocktwits.com/Biotoneten/message/643159817</stembedurl><a href="https://stocktwits.com/symbol/FEED">FEED stock</a> has lost about 94% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/cvna-shares-in-spotlight-after-gotham-city-research-highlights-red-flags/cmygaQtR400">CVNA Shares In Spotlight After Gotham City Research Highlights Red Flags — What Does The Street Think?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Is FEED Stock Soaring Over 130% Today?

ENvue Medical announced a distribution agreement with enteral feeding supplies provider U-Deliver. 

Equity

ENvue Medical announced a distribution agreement with enteral feeding supplies provider U-Deliver. 


This MedTech Stock Just Surged 81% on a Distribution Deal You Didn't See Coming

The home healthcare market continues to expand as patients and caregivers seek reliable medical solutions outside traditional hospital settings. Enteral feeding&#8212;delivering nutrition directly to the gastrointestinal tract&#8212;represents a critical segment of this market, with millions of Americans relying on tube feeding for daily nutrition and medication delivery. As care increasingly shifts from acute facilities to home environments, demand is growing for accessible, affordable products that maintain clinical standards.Shares of ENvue Medical, Inc. (NASDAQ: FEED) are soaring ...

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through NanoVibronix and ENvue segments. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

ENvue Medical Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$1.19
Prev Close	$1.32
Open	$1.36
Dividend Yield	0.00%
50-Day Moving Average	$1.68
Beta	0.65
Avg. Volume	235,338.07
PE Ratio	-0.02

52-Week High	$44.50
52-Week Low	$0.99
Market Capitalization	$4.4M
EPS (Annual)	-$26.69
Price to Book	0.04
Revenue Per Employee	$182,357.14

FEED
ENvue Medical, Inc. Common Stock

Feed

News

Sentiment

Fundamentals

Info

Latest FEED News

FEEDENvue Medical, Inc. Common Stock